Presentation Information

[1-S-05]NCLX inhibition as a therapeutic strategy for treatment of pulmonary arterial hypertension

*Satomi Kita1,2 (1. Dept. Pharmacol., Facul. Pharmaceut. Sci., Tokushima Bunri Univ. , 2. Dept. Pharmacol., Facul. Med., Fukuoka Univ.)

Keywords:

mitochondria,pulmonary arterial hypertension,transporter

Password required to view

Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.

Comment

To browse or post comments, you must log in.Log in